CURRICULUM VITAE

Kamran Bagheri Lankarani, MD

Faculty Member of GEHRC

Address: Department of Internal Medicine, Nemazee Hospital, Nemazee Square, Shiraz, Iran Tel: +98-711-6261089 Fax: +98-711-6261089 Email: [email protected] PERSONAL DATA: Birth Place: Tehran Birth Date: 16 Sep 1965 Married Three sons Educational Background

1978-1982 Shiraz University High School 1982-1989 School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran 1989-1992 Residency program in Department of Internal Medicine, Shiraz University of Medical Sciences 1992-1994 Fellowship program in Department of Internal Medicine (Gastroenterology & Hepatology) Shiraz University of Medical Sciences, Shiraz, Iran Professional Activities

1992-1999 Assistant Professor of Medicine, Department of Internal Medicine, Shiraz University of Medical Sciences, Shiraz, Iran 1993-1994 Manager of Nemazee General Hospital, Shiraz, Iran 1994-1996 Vice Chancellor of Shiraz University of Medical Sciences, Shiraz, Iran 1996-Present Head of the Internal Medicine Department, Shiraz University of Medical Sciences, Shiraz, Iran 1996-2005 Member of Board of Examiners in Comprehensive Internship Exam and Internal Medicine Certificate 2000-present Editor-in-Chief of Shiraz Electronic Medical Journal 2000-2005 Associate Professor of Medicine, Department of Internal Medicine, Shiraz, Iran 2004-present Member of Board of Examiners in Exam of Gastrointestinal and Liver Diseases of adults 2005-2018 Full professor of Internal Medicine, Department of Internal Medicine, Shiraz, Iran 2005-2009 Minister of Health and Medical Education 2006 Chairman of Regional Meeting of WHO 2009-present Director of Health Policy Research Center, Shiraz University of Medical Sciences, Shiraz, Iran 2009-2012 Editor-in-Chief of Iranian Red Crescent Medical Journal 2009-present Head of Board of Founders in Cultural Center of Vision 2010-present Permanent Member of Iran’s Academy of Medical Sciences 2010-present Chairman of Hepatitis Monthly Journal 2010-present Chairman of Health Key Journal (affiliated with Health Policy Research Center) 2014-present Editor-in-Chief of Annals of Colorectal Research 2014-present Chairman of International Journal of School Health and Women’s Health Bulletin 2017 Distinguished Professor of Shiraz University of Medical Sciences, Shiraz, Iran 2017-present Head of Health Promotion Group in Iranian Academy of Medical Sciences Membership in Scientific Societies

1992-present Member of the Iranian Society of Internists 1994-present Member of the Iranian Society of Gastroenterologist & Hepatologists 1997-1998 Member of the National Committee in revising Continuing Medical Education for Internists March 2003-present International member of American Gastenterological Association March 2003-present Member of international society for liver transplantation Editorial Board

1992-present Member of the Editorial Board of Khas journal (in Persian) 1996-present Member of the Editorial Board of Armaghane Danesh Journal (In Persian) 1999-present Member of the Editorial Board of Novin Pezeshki Journal (In Persian) 1996-present Consultant of the Iranian Journal of Medical Science 2001-present Chairman of Editorial Board and Founder of Shiraz Electronic Medical Journal 2005-present Chairman of Editorial Board of Hepatitis Monthly 2006-present Editorial Board Member of Iranian Journal of Medical Hypothesis Publications

1. Honarvar B, Salehi F, Shaygani F, Hajebrahimi M, Homayounfar R, Dehghan S, et al. Opportunities and Threats of Electronic Health in Management of Diabetes Mellitus: An Umbrella Review of Systematic Review and Meta-Analysis Studies. Shiraz E-Medical Journal. 2019;20(1). 2. Akbari M, Ostadmohammadi V, Mirhosseini N, Lankarani KB, Tabrizi R, Keshtkaran Z, et al. The effects of melatonin supplementation on blood pressure in patients with metabolic disorders: a systematic review and meta-analysis of randomized controlled trials. Journal of Human Hypertension. 2019:1. 3. Yusefi AR, Lankarani KB, Bastani P, Radinmanesh M, Kavosi Z. Risk Factors for Gastric Cancer: A Systematic Review. Asian Pacific journal of cancer prevention: APJCP. 2018;19(3):591. 4. Vardanjani HM, Haghdoost A, Bagheri-Lankarani K, Hadipour M. Estimation and Projection of Prevalence of Colorectal Cancer in Iran, 2015–2020. Advanced biomedical research. 2018;7. 5. Tabrizi R, Vakili S, Lankarani KB, Akbari M, Mirhosseini N, Ghayour-Mobarhan M, et al. The Effects of Curcumin on Glycemic Control and Lipid Profiles Among Patients with Metabolic Syndrome and Related Disorders: A Systematic Review and Meta-analysis of Randomized Controlled Trials. Current pharmaceutical design. 2018;24(27):3184-99. 6. Tabrizi R, Vakili S, Lankarani KB, Akbari M, Jamilian M, Mahdizadeh Z, et al. The Effects of Vitamin D Supplementation on Markers Related to Endothelial Function Among Patients with Metabolic Syndrome and Related Disorders: A Systematic Review and Meta-Analysis of Clinical Trials. Hormone and Metabolic Research. 2018;50(08):587-96. 7. Tabrizi R, Vakili S, Akbari M, Mirhosseini N, Lankarani KB, Rahimi M, et al. The effects of curcumin‐containing supplements on biomarkers of inflammation and oxidative stress: A systematic review and meta‐analysis of randomized controlled trials. Phytotherapy Research. 2018. 8. Tabrizi R, Tamtaji OR, Mirhosseini N, Lankarani KB, Akbari M, Dadgostar E, et al. The effects of statin use on inflammatory markers among patients with metabolic syndrome and related disorders: A systematic review and meta-analysis of randomized controlled trials. Pharmacological research. 2018. 9. Tabrizi R, Tamtaji OR, Lankarani KB, Mirhosseini N, Akbari M, Dadgostar E, et al. The effects of resveratrol supplementation on biomarkers of inflammation and oxidative stress among patients with metabolic syndrome and related disorders: a systematic review and meta-analysis of randomized controlled trials. Food & function. 2018;9(12):6116-28. 10. Tabrizi R, Tamtaji OR, Lankarani KB, Akbari M, Dadgostar E, Dabbaghmanesh MH, et al. The effects of resveratrol intake on weight loss: a systematic review and meta-analysis of randomized controlled trials. Critical reviews in food science and nutrition. 2018:1-16. 11. Tabrizi R, Saneei P, Lankarani KB, Akbari M, Kolahdooz F, Esmaillzadeh A, et al. The effects of caffeine intake on weight loss: a systematic review and dos-response meta-analysis of randomized controlled trials. Critical reviews in food science and nutrition. 2018:1-9. 12. Tabrizi R, Ostadmohammadi V, Lankarani KB, Peymani P, Akbari M, Kolahdooz F, et al. The effects of inositol supplementation on lipid profiles among patients with metabolic diseases: a systematic review and meta-analysis of randomized controlled trials. Lipids in health and disease. 2018;17(1):123. 13. Tabrizi R, Moosazadeh M, Razzaghi A, Akbari M, Heydari ST, Kavari SH, et al. Prevalence of sleep quality disorder among Iranian drivers: a systematic review and meta-analysis. Journal of injury and violence research. 2018;10(1):53. 14. Tabrizi R, Moosazadeh M, Lankarani KB, Akbari M, Heydari ST, Kolahdooz F, et al. The effects of synbiotic supplementation on glucose metabolism and lipid profiles in patients with diabetes: A systematic review and meta-analysis of randomized controlled trials. Probiotics and antimicrobial proteins. 2018;10(2):329-42. 15. Tabrizi R, Lankarani KB, Akbari M, Naghibzadeh-Tahami A, Alizadeh H, Honarvar B, et al. The effects of folate supplementation on lipid profiles among patients with metabolic diseases: A systematic review and meta-analysis of randomized controlled trials. Diabetes & Metabolic Syndrome: Clinical Research & Reviews. 2018;12(3):423-30. 16. Tabrizi R, Akbari M, Sharifi N, Lankarani KB, Moosazadeh M, Kolahdooz F, et al. The effects of coenzyme Q10 supplementation on blood pressures among patients with metabolic diseases: a systematic review and meta-analysis of randomized controlled trials. High Blood Pressure & Cardiovascular Prevention. 2018:1-10. 17. Tabrizi R, Akbari M, Lankarani KB, Heydari ST, Kolahdooz F, Asemi Z. The effects of vitamin D supplementation on endothelial activation among patients with metabolic syndrome and related disorders: a systematic review and meta-analysis of randomized controlled trials. Nutrition & metabolism. 2018;15(1):85. 18. Sadati AK, Tabei SZ, Lankarani KB. A Qualitative Study on the Importance and Value of Doctor-Patient Relationship in Iran: Physicians’ Views. Open access Macedonian journal of medical sciences. 2018;6(10):1895. 19. Rajabi A, Maharlouei N, Rezaianzadeh A, Lankarani KB, Esmaeilzadeh F, Gholami A, et al. Physical activities (exercises or choreses) during pregnancy and mode of delivery in nulliparous women: A prospective cohort study. Taiwanese Journal of Obstetrics and Gynecology. 2018;57(1):18-22. 20. Rahnavard F, Sadati AK, Hemmati S, Ebrahimzade N, Sarikhani Y, Heydari ST, et al. The impact of environmental and demographic factors on nursing job satisfaction. Electronic physician. 2018;10(4):6712. 21. Moudi B, Heidari Z, Mahmoudzadeh-Sagheb H, Alavian S-M, Lankarani KB, Farrokh P, et al. Concomitant use of heat-shock protein 70, glutamine synthetase and glypican-3 is useful in diagnosis of HBV-related hepatocellular carcinoma with higher specificity and sensitivity. European journal of histochemistry: EJH. 2018;62(1). 22. Motallebi N, Davoodzadeh K, Borjalilu S, Kashanimovahhed B, Anbari M, Nikfarjad H, et al. The Influential Aspects of Cyberspace in Promotion of Sports. Asian Journal of Sports Medicine. 2018;9(3). 23. Maharlouei N, Tabrizi R, Lankarani KB, Rezaianzadeh A, Akbari M, Kolahdooz F, et al. The effects of ginger intake on weight loss and metabolic profiles among overweight and obese subjects: A systematic review and meta-analysis of randomized controlled trials. Critical reviews in food science and nutrition. 2018:1-14. 24. Maharlouei N, Mansouri P, Zahmatkeshan M, Lankarani K. Low-risk planned caesarean versus planned vaginal delivery at term: early and late infantile outcomes. East Mediterr Health J. 2018;24:2-. 25. Maharlouei N, Atefi S, Lankarani K. A Study Protocol to Follow a Birth Cohort: Fars Birth Cohort. Shiraz E-Medical Journal. 2018(In Press). 26. Lankarani KB, Hosseini SAM. The Situation of Liver Transplantation Programs in Iran. Middle East journal of digestive diseases. 2018;10(3):194. 27. Lankarani KB, Ghahramani S, Moradi N, Shahraki HR, Lotfi F, Honarvar B. Willingness-to-Pay for One Quality-Adjusted Life-Year: A Population-Based Study from Iran. Applied health economics and health policy. 2018;16(6):837-46. 28. LANKARANI KB, Ghahramani S. Does" Overall Catastrophic Health Care Expenditure" Make Sense? Iranian journal of public health. 2018;47(8):1228-9. 29. Lankarani KB, Akbari M, Tabrizi R, Derakhshan I. Association between Gastrointestinal Functional Disorders and Migraine Headache: A Therapeutic Link. 2018. 30. Lankarani KB. Challenging issues in the management of Wilson's disease. Clinics and research in hepatology and gastroenterology. 2018;42(6):e95-e6. 31. Khamesipour F, Lankarani KB, Honarvar B, Kwenti TE. A systematic review of human pathogens carried by the housefly (Musca domestica L.). BMC public health. 2018;18(1):1049. 32. Jorat MV, Tabrizi R, Mirhosseini N, Lankarani KB, Akbari M, Heydari ST, et al. The effects of coenzyme Q10 supplementation on lipid profiles among patients with coronary artery disease: a systematic review and meta-analysis of randomized controlled trials. Lipids in health and disease. 2018;17(1):230. 33. Honarvar B, Lankarani KB, Taghavi M, Vahedi G, Mortaz E. Biomarker-guided antifungal stewardship policies for patients with invasive candidiasis. Current Medical Mycology. 2018. 34. Honarvar B, Lankarani KB, Kazemi M, Shaygani F, Sekhavati E, Raooufi A, et al. Five years after implementation of urban family physician program in fars province of Iran: Are people's knowledge and practice satisfactory? International journal of preventive medicine. 2018;9. 35. Heydari ST, Sadati AK, Goodarzi A, Izadi A, Sarikhani Y, Kazemi M, et al. The Effect of Quality Management on Happiness of Police Staff in Shiraz, Iran. Shiraz E-Medical Journal. 2018(In Press). 36. Heydari M, Dalfardi B, Golzari SE, Zaidi SMA, Lankarani KB, Mosavat SH. Koncept opstrukcije portalnog sustava u Aviceninu kanonu medicine. Acta medico-historica Adriatica. 2018;16(1):115-26. 37. Heydari M, Dalfardi B, Golzari SE, Zaidi SMA, Lankarani KB, Mosavat H. The concept of portal system obstruction in Avicenna's canon of medicine. AMHA-Acta medico-historica Adriatica. 2018;16(1):115-26. 38. Ghahramani S, Lankarani KB. Inpatient out-of-pocket in Iran after health transformation plan. International journal of health policy and management. 2018;7(9):877. 39. Geramizadeh B, Moughali M, Shahim-Aein A, Memari S, Ghetmiri Z, Taghavi A, et al. False negative and false positive rates in common bile duct brushing cytology, a single center experience. Gastroenterology and Hepatology from bed to bench. 2018;11(4):296. 40. Eshraghian K, Lankarani KB, Fattahi MR, Esmailnejad A, Peymani P. Low Prevalence of Insulin Resistance Among Iranian Patients with Chronic Hepatitis C Virus Infection: A Case-Control Study. Current diabetes reviews. 2018;14(5):446-50. 41. Bakhshayeshkaram M, Roozbeh J, Heydari ST, Honarvar B, Dabbaghmanesh MH, Ghoreyshi M, et al. A population-based study on the prevalence and risk factors of chronic kidney disease in adult population of shiraz, southern Iran. Galen Medical Journal. 2018:935. 42. Bakhshayeshkaram M, Lankarani KB, Mirhosseini N, Tabrizi R, Akbari M, Dabbaghmanesh MH, et al. The Effects of Coenzyme Q10 Supplementation on Metabolic Profiles of Patients with Chronic Kidney Disease: A Systematic Review and Meta-analysis of Randomized Controlled Trials. Current pharmaceutical design. 2018;24(31):3710-23. 43. Bakhshayeshkaram M, Lankarani K, Mirhosseini N, Tabrizi R, Akbari M, Dabbaghmanesh M, et al. The effects of coenzyme Q10 supplementation on metabolic profiles of patients with chronic kidney disease: A systematic review and meta-analysis of randomized controlled trials. Current pharmaceutical design. 2018. 44. Arasteh P, Maharlouei N, Eghbali SS, Amini M, Lankarani KB, Malekzadeh R. A Comprehensive Look at Irritable Bowel Syndrome and its Associated Factors Considering the Rome IV Criteria: A Penalized Smoothly Clipped Absolute Deviation Regression Approach in the Pars Cohort Study. Middle East journal of digestive diseases. 2018;10(3):149. 45. Amanat S, Eftekhari MH, Fararouei M, Lankarani KB, Massoumi SJ. Genistein supplementation improves insulin resistance and inflammatory state in non-alcoholic fatty liver patients: A randomized, controlled trial. Clinical Nutrition. 2018;37(4):1210-5. 46. Akbari M, Tabrizi R, Lankarani KB, Heydari ST, Karamali M, Kashanian M, et al. The effects of folate supplementation on diabetes biomarkers among patients with metabolic diseases: a systematic review and meta-analysis of randomized controlled trials. Hormone and Metabolic Research. 2018. 47. Akbari M, Ostadmohammadi V, Tabrizi R, Mobini M, Lankarani KB, Moosazadeh M, et al. The effects of alpha-lipoic acid supplementation on inflammatory markers among patients with metabolic syndrome and related disorders: a systematic review and meta-analysis of randomized controlled trials. Nutrition & metabolism. 2018;15(1):39. 48. Akbari M, Ostadmohammadi V, Tabrizi R, Lankarani KB, Heydari ST, Amirani E, et al. The effects of melatonin supplementation on inflammatory markers among patients with metabolic syndrome or related disorders: A systematic review and meta-analysis of randomized controlled trials. Inflammopharmacology. 2018:1-9. 49. Akbari M, Ostadmohammadi V, Lankarani KB, Tabrizi R, Kolahdooz F, Khatibi SR, et al. The effects of alpha-lipoic acid supplementation on glucose control and lipid profiles among patients with metabolic diseases: A systematic review and meta-analysis of randomized controlled trials. Metabolism. 2018. 50. Akbari M, Ostadmohammadi V, Lankarani KB, Tabrizi R, Kolahdooz F, Heydari ST, et al. The Effects of vitamin D supplementation on biomarkers of inflammation and oxidative stress among women with polycystic ovary syndrome: A systematic review and meta-analysis of randomized controlled trials. Hormone and Metabolic Research. 2018;50(04):271-9. 51. Tabrizi R, Moosazadeh M, Lankarani KB, Akbari M, Heydari ST, Kolahdooz F, et al. The effects of vitamin D supplementation on metabolic profiles and liver function in patients with non-alcoholic fatty liver disease: A systematic review and meta-analysis of randomized controlled trials. Diabetes & Metabolic Syndrome: Clinical Research & Reviews. 2017;11:S975-S82. 52. Tabrizi R, Akbari M, Moosazadeh M, Lankarani KB, Heydari ST, Kolahdooz F, et al. The effects of selenium supplementation on glucose metabolism and lipid profiles among patients with metabolic diseases: a systematic review and meta-analysis of randomized controlled trials. Hormone and Metabolic Research. 2017;49(11):826-30. 53. Sarikhani Y, Heydari ST, Gholamzadeh S, Mazloom M, Peymani P, Lankarani KB, et al. Burden of traffic accidents among pedestrians of Fars province, southern Iran; estimate of years of life lost in a sample of Iranian population from 2009 to 2013. Chinese journal of traumatology. 2017;20(5):259-63. 54. Sadati AK, Rahnavard F, Heydari ST, Hemmati S, Ebrahimzadeh N, Lankarani KB. Health Sector Reform, Emotional Exhaustion, and Nursing Burnout: A Retrospective Panel Study in Iran. journal of nursing research. 2017;25(5):368-74. 55. Sadati AK, Lankarani KB. The pattern of educator voice in clinical counseling in an educational hospital in Shiraz, Iran: a conversation analysis. Journal of medical ethics and history of medicine. 2017;10. 56. Sadati AK, Lankarani KB. A Proposed Model about Physician-Patient Interaction according to Islamic Concepts. Sadra Medical Sciences Journal. 2017;2(3). 57. Rahmanian A, Jamali M, Lankarani KB, Ghahramani S. Aneurysmal subarachnoid haemorrhage (aSAH): Five consecutive years' experience of Fars province, Iran. PloS one. 2017;12(11):e0189005. 58. Parvizi MM, Nimrouzi M, Lankarani KB, Alorizi SME, Hajimonfarednejad M, Almasi A, et al. Health Recommendations for the Elderly in the Viewpoint of Traditional Persian Medicine. Health. 2017;18:9. 59. Parvizi MM, Lankarani KB, Handjani F, Ghahramani S, Parvizi Z, Rousta S. Health literacy in patients with epidermolysis bullosa in Iran. Journal of education and health promotion. 2017;6. 60. Mosaffa-Jahromi M, Tamaddon A-M, Afsharypuor S, Salehi A, Seradj SH, Pasalar M, et al. Effectiveness of Anise Oil for Treatment of Mild to Moderate Depression in Patients With Irritable Bowel Syndrome: A Randomized Active and Placebo-Controlled Clinical Trial. Journal of evidence-based complementary & alternative medicine. 2017;22(1):41-6. 61. Moosazadeh M, Asemi Z, Lankarani KB, Tabrizi R, Maharlouei N, Naghibzadeh-Tahami A, et al. Family history of diabetes and the risk of gestational diabetes mellitus in Iran: a systematic review and meta-analysis. Diabetes & Metabolic Syndrome: Clinical Research & Reviews. 2017;11:S99-S104. 62. Maharlouei N, Akbari M, Akbari M, Lankarani KB. Socioeconomic Status and Satisfaction with Public Healthcare System in Iran. International journal of community based nursing and midwifery. 2017;5(1):22. 63. Lankarani KB, Taghavi SA, Pahlavan MS, Malek-Hosseini SA. Cytomegalovirus Peritonitis Without Gut Perforation But With Concomitant Colitis After a Liver Allograft Transplant. Experimental and clinical transplantation: official journal of the Middle East Society for Organ Transplantation. 2017;15(1):106-9. 64. Lankarani KB, Sepehrimanesh M, Seghatoleslam SF, Hoseini SE, Ghavami S. Autophagy-related protein 7 level in patients with ulcerative colitis. Scandinavian journal of gastroenterology. 2017;52(4):468-. 65. Lankarani KB, Ghahramani S, Honarvar B. A study on hospitalized patients’ payment in south of Iran after the first round of health sector reform. Iranian journal of public health. 2017;46(2):276. 66. Lankarani KB, Akbari M, Tabrizi R. Association of Gastrointestinal Functional Disorders and Migraine Headache: a Population Base Study. Middle East journal of digestive diseases. 2017;9(3):139. 67. Lankarani K, Khosravizadegan Z, Naghibzadeh-Tahami A, Akbari M, Khodadost M, Honarvar B, et al. Opium use and risk of lower gastrointestinal cancers: Population-based case-control study in South of Iran. International Journal of Cancer Management. 2017;10(6). 68. Lankaran KB, Khankeh HR, Zarei N, Fararouei M, Saboori Z, Joulaei H. Toward equity under health system reform; a systematic review. Shiraz E-Medical Journal. 2017;18(11). 69. Joulaei H, Lankarani KB, Kazerooni PA, Marzban M. Number of HIV-infected cases in Iran: True or just an iceberg. Indian Journal of Sexually Transmitted Diseases and AIDS. 2017;38(2):157. 70. Hosseinkhani A, Lankarani K, Mohagheghzadeh A, Long C, Pasalar M. An Evidence-based Review of Medicinal Herbs for the Treatment of Gastroesophageal Reflux Disease (GERD). Current drug discovery technologies. 2017. 71. Hosseini SAM, Nikeghbalian S, Salahi H, Kazemi K, Shemsaeifar A, Bahador A, et al. Evolution of Liver Transplantation Program in Shiraz, Iran. Hepatitis Monthly. 2017;17(11). 72. Honarvar B, Moghadami M, Lankarani K, Davarpanah M, Ataolahi M, Farbod A, et al. Brucellosis as a neglected disease in a neglected population: a seroepidemiological study of migratory nomads in the Fars province of Iran. Epidemiology & Infection. 2017;145(3):491-7. 73. Honarvar B, Lankarani KB, Keshani P, Rafiee T. Dietary Determinants of Non-Alcoholic Fatty Liver Disease in Lean and Non-Lean Adult Patients: A Population-Based Study in Shiraz, Southern Iran. Hepatitis Monthly. 2017;17(4). 74. Heydari MR, SADATI AK, LANKARANI KB, Imanieh MH, Baghi H, Lolia MJ. The Evaluation of Urban Community Health Centers in Relation to Family Physician and Primary Health Care in Southern Iran. Iranian journal of public health. 2017;46(12):1726. 75. Ghorbanian A, Rashidian A, Lankarani KB, Kavosi Z. The Prevalence and Determinants of Catastrophic Health Expenditures in Iran: A Systematic Review and Meta-Analysis. Health Scope. 2017(In Press). 76. Anushiravani A, Faghihi MA, Dastsooz H, Lankarani KB. Glycogen storage disease IIIa: A private homozygous splice site mutation in AGL gene. Gene Reports. 2017;9:61-4. 77. Akbari M, Mosazadeh M, Lankarani KB, Tabrizi R, Samimi M, Karamali M, et al. The effects of vitamin D supplementation on glucose metabolism and lipid profiles in patients with gestational diabetes: a systematic review and meta-analysis of randomized controlled trials. Hormone and Metabolic Research. 2017;49(09):647-53. 78. Akbari M, Moosazadeh M, Tabrizi R, Khatibi SR, Khodadost M, Heydari ST, et al. Estimation of iron deficiency anemia in Iranian children and adolescents: a systematic review and meta-analysis. Hematology. 2017;22(4):231-9. 79. Akbari M, Moosazadeh M, Lankarani KB, Tabrizi R, Samimi M, Karamali M, et al. Correction: The effects of vitamin D supplementation on glucose metabolism and lipid profiles in patients with gestational diabetes: A systematic review and meta-analysis of randomized controlled trials. Hormone and Metabolic Research. 2017;49(09):e3-e. 80. Akbari M, Moosazadeh M, Ghahramani S, Tabrizi R, Kolahdooz F, Asemi Z, et al. High prevalence of hypertension among Iranian children and adolescents: a systematic review and meta- analysis. Journal of hypertension. 2017;35(6):1155-63. 81. Tabrizia R, Akbaria M, Lankarania KB, Heydaria ST, Masoudi A, Shams AH, et al. Received: 30 July 2016 Revised: 5 September 2016 Accepted: 12 December 2016. 2016. 82. Sadati AK, Tabei SZ, Ebrahimzade N, Zohri M, Argasi H, Lankarani KB. The paradigm model of distorted doctor-patient relationship in Southern Iran: a grounded theory study. Journal of Medical Ethics and History of Medicine. 2016;9. 83. Sadati AK, Lankarani KB, Hemmati S. Patients’ description of unexpected interactions: a critical ethnography of the quality of doctor-patient interactions in one educational hospital in Shiraz, Iran. Shiraz E-Medical Journal. 2016;17(7-8). 84. Sadati AK, Iman MT, Lankarani KB, Ebrahimzadeh N. From good to great physician: a critical ethnography based on patients' views. Journal of medical ethics and history of medicine. 2016;9. 85. Sadati AK, Iman MT, Lankarani KB, Derakhshan S. A critical ethnography of doctor–patient interaction in southern Iran. Indian J Med Ethics. 2016;1(3):147-55. 86. Sadati AK, Hemmati S, Rahnavard F, Lankarani KB, Heydari ST. The impact of demographic features and environmental conditions on rates of nursing burnout. Shiraz E-Medical Journal. 2016;17(3). 87. Rajabi A, Maharlouei N, Rezaianzadeh A, Rajaeefard A, Keshavarzi S, Lankarani KB, et al. Non- medical factors affecting antenatal preferences for delivery route and actual delivery mode of women in southwestern Iran. The Journal of Maternal-Fetal & Neonatal Medicine. 2016;29(22):3622-8. 88. Peymani P, Yeganeh B, Sabour S, Geramizadeh B, Fattahi MR, Keyvani H, et al. New use of an old drug: chloroquine reduces viral and ALT levels in HCV non-responders (a randomized, triple-blind, placebo-controlled pilot trial). Canadian journal of physiology and pharmacology. 2016;94(6):613-9. 89. Peymani P, Tabrizi R, Afifi S, Namazi S, Heydari ST, Shirazi MK, et al. Knowledge, attitude and practice of General Practitioners towards adverse drug reaction reporting in South of Iran, Shiraz (Pharmacoepidemiology report). International Journal of Risk & Safety in Medicine. 2016;28(1):25-31. 90. Peymani P, Ghavami S, Yeganeh B, Tabrizi R, Sabour S, Geramizadeh B, et al. Effect of chloroquine on some clinical and biochemical parameters in non-response chronic hepatitis C virus infection patients: pilot clinical trial. Acta Bio Medica Atenei Parmensis. 2016;87(1):46-53. 91. Pasalar M, Nimrouzi M, Choopani R, Mosaddegh M, Kamalinejad M, Mohagheghzadeh A, et al. Functional dyspepsia: A new approach from traditional Persian medicine. Avicenna journal of phytomedicine. 2016;6(2):165. 92. Pasalar M, Mosaffa-Jahromi M, Lankarani KB. Toward Food Therapy for Irritable Bowel Syndrome. The American journal of gastroenterology. 2016;111(10):1499. 93. Pasalar M, Choopani R, Rezaeizadeh H, Ranjbar M, Lankarani K. A traditional Persian medicine beverage could improve quality of life in dyspeptic patients. Planta Medica. 2016;82(S 01):P1008. 94. Parvizi Z, Sadati AK, Azarpira N, Tabrizi R, Heydari S, Lankarani K. Study of quality of life among liver transplant candidates in Shiraz, Southwestern Iran. Galen Med J. 2016;5(04):180-7. 95. Mosaffa-Jahromi M, Lankarani KB, Pasalar M, Afsharypuor S, Tamaddon A-M. Efficacy and safety of enteric coated capsules of anise oil to treat irritable bowel syndrome. Journal of ethnopharmacology. 2016;194:937-46. 96. Moosazadeh M, Lankarani KB, Afshari M. Meta-analysis of the prevalence of Helicobacter pylori infection among children and adults of Iran. International journal of preventive medicine. 2016;7. 97. Moosazadeh M, Akbari M, Tabrizi R, Ghorbani A, Golkari A, Banakar M, et al. Denture stomatitis and Candida Albicans in Iranian population: A systematic review and meta-analysis. Journal of Dentistry. 2016;17(3 Suppl):283. 98. Moghaddasifar I, Lankarani KB, Moosazadeh M, Afshari M, Malary M. Prevalence of hepatitis B virus infection among pregnant women in Iran: A systematic review and meta-analysis. Iranian Journal of Cancer Prevention. 2016;9(6). 99. Moghaddasifar I, Lankarani K, Moosazadeh M, Afshari M, Ghaemi A, Aliramezany M, et al. Prevalence of non-alcoholic fatty liver disease and its related factors in Iran. International journal of organ transplantation medicine. 2016;7(3):149. 100. Masoompour SM, Lankarani KB, Honarvar B, Tabatabaee SH, Moghadami M, Khosravizadegan Z. Changing epidemiology of common cancers in southern iran, 2007-2010: A cross sectional study. PloS one. 2016;11(5):e0155669. 101. Maharlouei N, Akbari M, Shirazy MK, Yazdanpanah D, Lankarani K. Factors associated with self-rated health status in Southwestern Iran: a population-based study. Public health. 2016;140:179-85. 102. Lankarani KB, Malek-Hosseini SA, Nikeghbalian S, Dehghani M, Pourhashemi M, Kazemi K, et al. Fourteen years of experience of liver transplantation for Wilson’s Disease; a report on 107 Cases from Shiraz, Iran. PloS one. 2016;11(12):e0167890. 103. Lankarani KB, Maharlouei N, Akbari M, Yazdanpanah D, Akbari M, Moghadami M, et al. Satisfaction rate regarding health-care services and its determinant factors in South-West of Iran: A population-based study. International journal of preventive medicine. 2016;7. 104. Lankarani KB, Hojati SA, Heydari ST. Use of C-Reactive Protein as a Diagnostic Tool for Early Detection of Bacterial Infection After Liver Transplantation. Hepatitis monthly. 2016;16(9). 105. Lankarani KB, Ghahramani S, Bagheri A, Dehghan Y, Kasraei F, Keshtkar M, et al. Elderly perceptions about road traffic injuries in Shiraz, Southern Iran. Shiraz e-medical journal. 2016;17(3). 106. Lankarani KB, Ardebili M, Sepehrimanesh M, Nejabat M, Rad MAH, Hosseini SY. Evaluation of hepatitis C virus intrafamilial transmission among families with one index case, a pilot study from Fars province, Iran. Gastroenterology and Hepatology from bed to bench. 2016;9(4):250. 107. Khashei R, Dara M, Bazargani A, Bagheri Lankarani K, Taghavi A, Moeini M, et al. High rate of A2142G point mutation associated with clarithromycin resistance among Iranian Helicobacter pylori clinical isolates. Apmis. 2016;124(9):787-93. 108. Kalateh AS, Tabei SZ, Ebrahimzade N, Zohri M, Argasi H, Bagheri KL. The paradigm model of distorted doctor-patient relationship in Southern Iran: a grounded theory study. Journal of medical ethics and history of medicine. 2016;9:2-. 109. Joulaei H, Maharlouei N, Tabrizi R, Lankarani KB. The Millennium Development Goals; A Global Assignment. Shiraz E-Medical Journal. 2016;17(1). 110. Honarvar B, Salehi F, Barfi R, Asadi Z, Honarvar H, Odoomi N, et al. Attitudes toward and experience of singles with premarital sex: A population-based study in Shiraz, southern Iran. Archives of sexual behavior. 2016;45(2):395-402. 111. Honarvar B, Lankarani KB, Ghahramani S, Akbari M, Tabrizi R, Bagheri Z, et al. Satisfaction and dissatisfaction toward urban family physician program: A population based study in Shiraz, Southern Iran. International journal of preventive medicine. 2016;7. 112. Heydari ST, Vossoughi M, Akbarzadeh A, Lankarani KB, Sarikhani Y, Javanmardi K, et al. Prevalence and risk factors of alcohol and substance abuse among motorcycle drivers in Fars province, Iran. Chinese journal of traumatology. 2016;19(2):79-84. 113. Heydari ST, Lankarani KB, Vossoughi M, Javanmardi K, Sarikhani Y, Mahjoor K, et al. The prevalence and effective factors of crash helmet usage among motorcyclists in Iran. Journal of injury and violence research. 2016;8(1):1. 114. Heidari A, Mancin M, Nili H, Pourghanbari G, Lankarani K, Leardini S, et al. Serological evidence of H9N2 avian influenza virus exposure among poultry workers from Fars province of Iran. Virology journal. 2016;13(1):16. 115. Behzadifar M, Lankarani KB, Abdi S, Mirghaed MT, Beyranvand G, Keshavarzi A, et al. Seroprevalence of Hepatitis E Virus in Iran: A Systematic Review and Meta-analysis. Middle East journal of digestive diseases. 2016;8(3):189. 116. Alavian SM, Hajarizadeh B, Lankarani KB, Sharafi H, Daryani NE, Merat S, et al. Recommendations for the clinical management of hepatitis C in Iran: a consensus-based national guideline. Hepatitis monthly. 2016;16(8). 117. Akbari M, Lankarani KB, Honarvar B, Tabrizi R, Mirhadi H, Moosazadeh M. Prevalence of malocclusion among Iranian children: A systematic review and meta-analysis. Dental research journal. 2016;13(5):387. 118. Yeganeh B, Moghadam AR, Alizadeh J, Wiechec E, Alavian SM, Hashemi M, et al. Hepatitis B and C virus-induced hepatitis: Apoptosis, autophagy, and unfolded protein response. World journal of gastroenterology. 2015;21(47):13225. 119. Valizadeh L, Hosseini FA, Zamanzadeh V, Heidarnezhad F, Jasemi M, Lankarani KB. Practice of Iranian adolescents with hemophilia in prevention of complications of hemophilia. Indian Journal of Palliative Care. 2015;21(3):328. 120. Salehi A, Naghshvarian M, Marzban M, Lankarani KB. Prevalence of HIV, HCV, and high-risk behaviors for substance users in drop in centers in southern Iran. Journal of addiction medicine. 2015;9(3):181-7. 121. Sadati AK, Lankarani KB, Gharibi V, Fard ME, Ebrahimzadeh N, Tahmasebi S. Religion as an empowerment context in the narrative of women with breast cancer. Journal of religion and health. 2015;54(3):1068-79. 122. Sadati AK, Lankarani KB, Afrasiabi H. Medical sociology; a neglected academic discipline in Iran. Shiraz E-Medical Journal. 2015;16(5). 123. Roozbeh J, Bagheri-Lankarani K, Mohaghegh P, Raeesjalali G, Behzadi S, Sagheb M, et al. A randomized pilot trial on the effect of granulocyte-colony stimulating factor on antibody response in hemodialysis patients who had not responded to routine hepatitis B virus vaccine. Journal of nephropathology. 2015;4(1):13. 124. Rezaei S, Bagheri Lankarani K, Karami Matin B, Bazyar M, Hamzeh B, Najafi F. Determinant of Road Traffic Crash Fatalities in Iran: A Longitudinal Econometric Analysis. Journal of research in health sciences. 2015;15(3):163-7. 125. Pasalar M, Mosaffa Jahromi M, Afsharypuor S, Choopani R, Mosaddegh M, Kamalinejad M, et al. Preventive care for gastrointestinal disorders; role of herbal medicines in traditional persian medicine. Jundishapur Journal of Natural Pharmaceutical Products. 2015;10(4). 126. Pasalar M, Lankarani KB, Gerber LM, Mamtani R, Chiu Y-L, Bener A, et al. Considering traditional and folklore medicine in regional health systems/Author response. Eastern Mediterranean Health Journal. 2015;21(5):359. 127. Pasalar M, Lankarani KB. Herbal medicines, a prominent component in complementary and alternative medicine use in gastrointestinal field. The American journal of gastroenterology. 2015;110(6):935. 128. Pasalar M, Lankarani K. prunes for the treatment of constipation. Alimentary pharmacology & therapeutics. 2015;41(2):234-. 129. Pasalar M, Choopani R, Mosaddegh M, Kamalinejad M, Mohagheghzadeh A, Fattahi MR, et al. Efficacy of Jollab in the treatment of depression in dyspeptic patients: a randomized double-blind controlled trial. Journal of evidence-based complementary & alternative medicine. 2015;20(2):104-8. 130. Pasalar M, Choopani R, Mosaddegh M, Kamalinejad M, Mohagheghzadeh A, Fattahi MR, et al. Efficacy and Safety of Jollab to Treat Functional Dyspepsia: A Randomized Placebo–Controlled Clinical Trial. Explore: The Journal of Science and Healing. 2015;11(3):199-207. 131. Motamedifar M, Taheri M, Lankarani KB, Gholami M. The prevalence and risk factors of hepatitis delta virus in HIV/HBV co-infected patients in Shiraz, Iran, 2012. Iranian journal of medical sciences. 2015;40(5):448. 132. Moghadami M, Masoumpoor M, Tabei S, Tabaei S, Sadeghi H, Gholami K, et al. Therapeutic Response to Folinic Acid in Me-thanol Poisoning Epidemic in Shiraz. Iranian Journal of Medical Sciences. 2015;33(1):22-6. 133. Lankarani KB, Peymani P, Zare S, Tabrizi R, Kazemi M, Omrani G. Prevalence of vitamin b12 and folate deficiencies and homocysteinemia in elderly population of Shiraz, southern Iran. Tropical Journal of Pharmaceutical Research. 2015;14(10):1907-12. 134. Lankarani KB, Mowla A, Asadian F, Tabei S, Panjeshahin M. Changing Epidemiology of Esophageal Can-cer in Fars Province, Iran. Iranian Journal of Medical Sciences. 2015;27(1):4-10. 135. Lankarani KB, Homayon K, Motevalli D, Heidari ST, Alavian SM, Malek-Hosseini SA. Risk factors for portal vein thrombosis in patients with cirrhosis awaiting liver transplantation in Shiraz, Iran. Hepatitis monthly. 2015;15(12). 136. Lankarani KB, Ghoreyshi M, Bakhshayeshkaram M, Honarvar B, Sadati AK, Tabrizi R, et al. Meeting Report on First International Mobile Health Seminar: Shiraz, Iran, 17th and 18th May 2015. Shiraz E-Medical Journal. 2015;16(8). 137. Lankarani KB, Ghahramani S, Zakeri M, Joulaei H. Lessons learned from national health accounts in Iran: highlighted evidence for policymakers. Shiraz E-Medical Journal. 2015;16(4). 138. Lankarani KB, Ghaffarpasand F, Mahmoodi M, Dehghankhalili M, Honarvar B, Lotfi M, et al. Predictors of Common Carotid Artery Intima-Media Thickness and Atherosclerosis in a Sample of Iranian General Population. Shiraz E-Medical Journal. 2015;16(5). 139. Lankarani KB, Ghaffarpasand F, Honarvar B, Mahmoodi M, Mirzaee O, Mehravar S, et al. Socioeconomic Determinants of Health: An Adult Population Based Study in Shiraz, Southern Iran. Shiraz E-Medical Journal. 2015;16(4). 140. Lankarani KB, Alinejad ZM, Mooghali A, Joulaei H, Akbari M, Heshmati B. An analytical study of health system managers’ decision-making models. Shiraz E-Medical Journal. 2015;16(8). 141. LANKARANI KB, ALAVIAN SM. Low Carbohydrate Rather Than Low Fat Is More Important in Dietary Management of Nonalcoholic Steatohepatitis. Gastroenterology. 2015;1:1. 142. Lankarani KB. Changing population policy in Iran. Shiraz E-Medical Journal. 2015;16(2). 143. Lankarani K. Infliximab for treatment of pyoderma gangrenosum. The Netherlands journal of medicine. 2015;73(7):357-. 144. Keshavarzi S, Ahmadi SM, Lankarani KB. The impact of depression and malnutrition on health- related quality of life among the elderly Iranians. Global journal of health science. 2015;7(3):161. 145. Honarvar B, Lankarani KB, Rostami S, Honarvar F, Akbarzadeh A, Odoomi N, et al. Knowledge and practice of people toward their rights in urban family physician program: A population-based study in Shiraz, Southern Iran. International journal of preventive medicine. 2015;6. 146. Haem E, Heydari ST, Zare N, Lankarani KB, Barooti E, Sharif F. Ovarian Cancer Risk Factors in a Defined Population Using Rare Event Logistic Regression. Middle East Journal of Cancer. 2015;6(1):1- 9. 147. Haddadi MH, Bazargani A, Khashei R, Fattahi MR, Lankarani KB, Moini M, et al. Different distribution of Helicobacter pylori EPIYA-cagA motifs and dupA genes in the upper gastrointestinal diseases and correlation with clinical outcomes in iranian patients. Gastroenterology and Hepatology from bed to bench. 2015;8(Suppl1):S37. 148. Ghafouri-Fard S, Fardaei M, Lankarani KB, Miryounesi M. Segregation of a novel MLH1 mutation in an Iranian Lynch syndrome family. Gene. 2015;570(2):304-5. 149. Foroutan A, Paydar S, Heydari ST, Erjaee G, Lankarani KB, Nowroozi A, et al. Predictive Potential of Heart Rate Complexity Measurement: An Indication for Laparotomy Following Solid Organ Injury. Trauma monthly. 2015;20(4). 150. Ebrahimzade N, Mooghali A, Lankarani KB, Sadati AK. Relationship between nursing managers’ leadership styles and nurses’ job burnout: A study at Shahid Dr. Faghihi Hospital, Shiraz, Iran. Shiraz E-Medical Journal. 2015;16(8). 151. Behzad-Behbahani A, Mafi-Nejad A, Tabei S, Lankarani K, Rashidi M, Rasouli M, et al. Indication of anti-HBc antibody screening and HBV-DNA detection in diagnosing latent hepatitis B virus infection. Iranian Journal of Medical Sciences. 2015;30(1):28-33. 152. Akbari M, Tabrizi R, Heydari ST, Sekhavati E, Moosazadeh M, Lankarani KB. Prediction of trauma-specific death rates of pedestrians of Fars Province, Iran. Electronic physician. 2015;7(5):1247. 153. Ahmadi SM, Keshavarzi S, Mostafavi S-A, Lankarani KB. Depression and obesity/overweight association in elderly women: a community-based case-control study. Acta Medica Iranica. 2015;53(11):686-9. 154. Sadati AK, Lankarani KB, Enayat H, Kazerooni AR, Ebrahimzadeh S. Clinical paternalistic model and problematic situation: a critical evaluation of clinical counseling. Journal of health sciences and surveillance system. 2014;2(2):78-87. 155. Sadati AK, Iman MT, Lankarani KB. Quality and Frequency of Human Fellow Voice used in Doctor-Patient Interaction (One Qualitative Study in Clinical Counseling). Bioethics Journal. 2014;4(12):101-29. 156. Sadati AK, Iman MT, Lankarani KB. Medical paraclinical standards, political economy of clinic, and patients’ clinical dependency; A critical conversation analysis of clinical counseling in South of Iran. International journal of community based nursing and midwifery. 2014;2(3):157. 157. Rakhshani T, Shojaiezadeh D, Lankarani KB, Rakhshani F, Kaveh MH, Zare N. The association of health-promoting lifestyle with quality of life among the Iranian elderly. Iranian Red Crescent Medical Journal. 2014;16(9). 158. Pasalar M, Zarshenas MM, Lankarani KB. Good Digestion is a Key Element for Healthy Hearts: An Appealing Concept from Avicenna’s Viewpoint. Medical Hypothesis, Discovery & Innovation Interdisciplinary Sciences Journal. 2014;1(1). 159. Mooghali A, Lankarani KB, Abedi H, Sarikhani Y. The Relationship Between Job Characteristics and Work-Family Conflict Among Married Women Employed in Clinical Wards of Shiraz University- Affiliated Hospitals. Women's Health Bulletin. 2014;2(1). 160. Maharlouei N, Khodayari M, Forouzan F, Rezaianzadeh A, Lankarani KB. The incidence rate of hip fracture in Shiraz, Iran during 2008–2010. Archives of osteoporosis. 2014;9(1):165. 161. Maharlouei N, Ahmadi SM, Lankarani B. Report on the Second Iranian International Conference on Women’s Health Held May 1 and 2, 2013 in Shiraz, IR Iran. Women's Health. 2014;1:e23654. 162. Lankarani KB, Talebzadeh M, Eshraghian A, Malek-Hosseini SA. Granulocyte colony stimulating factor adjuvant role on the immunological response to hepatitis B vaccine in patients with cirrhosis: a double blind randomized placebo controlled trial. Hepatitis monthly. 2014;14(5). 163. Lankarani KB, Sarikhani Y, Heydari ST, Joulaie H, Maharlouei N, Peimani P, et al. Traffic accidents in Iran, a decade of progress but still challenges ahead. Medical journal of the Islamic Republic of Iran. 2014;28:96. 164. Lankarani KB, Ravanbod MR, Aflaki E, Nazarinia MA, Rajaee A. High prevalence of Helicobacter pylori infection in Behcet’s disease. BMC gastroenterology. 2014;14(1):58. 165. Lankarani KB, Mahmoodi M, Honarvar B, Nematollahi P, Zamiri N, Ghaffarpasand F. Determinants of poor outcome in patients with hepatitis A infection: a four-year retrospective study in Shiraz, Southern Iran. Archives of virology. 2014;159(8):1901-7. 166. Lankarani KB, Joulaei H. School Health, an Important Issue in the New Millennium. International Journal of School Health. 2014;1(1). 167. Lankarani KB, Honarvar B, Ahmadi SM, Fard AP, Hajebrahimi M, Akbari M, et al. Meeting report on first national seminar of media and health: 7th August 2014, Shiraz, Iran. Shiraz E-Medical Journal. 2014;15(4). 168. Lankarani KB, Heydari ST, Aghabeigi MR, Moafian G, Hoseinzadeh A, Vossoughi M. The impact of environmental factors on traffic accidents in Iran. Journal of injury and violence research. 2014;6(2):64. 169. Lankarani KB, Eshraghian A, Nikeghbalian S, Janghorban P, Malek-Hosseini SA. New onset diabetes and impaired fasting glucose after liver transplant: risk analysis and the impact of tacrolimus dose. Exp Clin Transplant. 2014;12(1):46-51. 170. Lankarani KB, Afshari R. Alcohol consumption in Iran. The Lancet. 2014;384(9958):1927-8. 171. Lankarani KB. Opium, an oncogene or a marker of oncogenic behaviors? The American journal of gastroenterology. 2014;109(4):600. 172. Lankarani K. Is metoclopramide nasal spray an acceptable alternative to its oral form? Neurogastroenterology & Motility. 2014;26(6):885-. 173. Hosseinzadeh-Khezri R, Rahbarian M, Sarichloo M-E, Lankarani KB, Jahanihashemi H, Rezaee F. Evaluation effect of Logotherapy group on Mental health and hope to life of Patients with Colorectal Cancer receiving Chemotherapy. Bull Env Pharmacol Life Sci. 2014;3(5):164-9. 174. Heydari ST, Sarikhani Y, Lankarani KB, Shirazi MK. Burden of transportation injuries among children and adolescents of Fars province: analysis of Iran’s 20-year trends. Epidemiology and health. 2014;36. 175. Bayati M, Sarikhani Y, Rad EH, Heydari ST, Lankarani KB. An Analytical Study on Healthcare Inflation Rate and Its Most Important Components in Iran. Shiraz E-Medical Journal. 2014;15(4). 176. Afifi S, Maharloui N, Peymani P, Namazi S, Gharaei AG, Jahani P, et al. Adverse drug reactions reporting: pharmacists' knowledge, attitude and practice in Shiraz, Iran. International Journal of Risk & Safety in Medicine. 2014;26(3):139-45. 177. Zare N, Haem E, Lankarani KB, Heydari ST, Barooti E. Breast cancer risk factors in a defined population: weighted logistic regression approach for rare events. Journal of breast cancer. 2013;16(2):214-9. 178. Sarikhani Y, Lankarani KB. Mixed payment method, the experience of a new payment method for health service providers in family physician program in Iran. Shiraz E-Medical Journal. 2013;14(4). 179. Sami A, Moafian G, Najafi A, Aghabeigi M-R, Yamini N, Heydari S-T, et al. Educational level and age as contributing factors to road traffic accidents. Chin J Traumatol. 2013;16(5):281-5. 180. Safari A, Borhani-Haghighi A, Heydari ST, Lankarani KB. Increased Guillain-Barre syndrome admissions in Shiraz, southern Iran. Iranian journal of neurology. 2013;12(1):15. 181. Moghadami M, Ruzbahani H, Badiee P, Faramarzi A, Peymani P, Lankarani KB. Invasive fungal sinusitis in immunocompromised patients: a multicenter, university hospital experience in Shiraz. Advances in Infectious Diseases. 2013;3(04):263. 182. Moafian G, Aghabeigi MR, Hoseinzadeh A, Lankarani KB, Sarikhani Y, Heydari ST. An epidemiologic survey of road traffic accidents in Iran: analysis of driver-related factors. Chinese journal of traumatology. 2013;16(3):140-4. 183. Maharlouei N, Rezaianzadeh A, Hesami E, Moradi F, Mazloomi E, Joulaei H, et al. The preference of Iranian women to have normal vaginal or cesarean deliveries. Journal of research in medical sciences: the official journal of Isfahan University of Medical Sciences. 2013;18(11):943. 184. Maharlouei N, Moalaee M, Ajdari S, Zarei M, Lankarani KB. Caesarean delivery in south- western Iran: trends and determinants in a community-based survey. Medical Principles and Practice. 2013;22(2):184-8. 185. Maharlouei N, Bellissimo N, Ahmadi S, Lankarani K. Prevalence of metabolic syndrome in pre- and postmenopausal Iranian women. Climacteric. 2013;16(5):561-7. 186. Maharlouei N, Barooti E, Sharif F, Hosseini H, Lankarani KB. Prevalence and risk factors of reproductive tract infections among a defined population of Iranian women. Sexual health. 2013;10(4):311-5. 187. Maharlouei N, Ahmadi SM, Lankarani KB. Report on first iranian international conference on women’s health held june 14-15, 2012 in shiraz, iran. International journal of fertility & sterility. 2013;7(1):67. 188. Lankarani KB, Sivandzadeh GR, Hassanpour S. Oral manifestation in inflammatory bowel disease: a review. World journal of gastroenterology: WJG. 2013;19(46):8571. 189. Lankarani KB, Mahmoodi M, Lotfi M, Zamiri N, Heydari ST, Ghaffarpasand F, et al. Common carotid intima-media thickness in patients with non-alcoholic fatty liver disease: a population-based case- control study. The Korean Journal of Gastroenterology. 2013;62(6):344-51. 190. Lankarani KB, Mahmoodi M, Heydari ST, Joulaei H, Ghaffarpasand F, Maharlouei N, et al. The second international conference on reducing burden of traffic accidents, Shiraz, Iran. Journal of Injury and Violence Research. 2013;5(1):75. 191. Lankarani KB, Khosravizadegan Z, Rezaianzadeh A, Honarvar B, Moghadami M, Faramarzi H, et al. Data coverage of a cancer registry in southern Iran before and after implementation of a population- based reporting system: a 10-year trend study. BMC health services research. 2013;13(1):169. 192. Lankarani KB, Ghaffarpasand F, Mahmoodi M, Lotfi M, Zamiri N, Heydari ST, et al. Non alcoholic fatty liver disease in southern Iran: a population based study. Hepatitis monthly. 2013;13(5). 193. Lankarani KB, Ghaffarpasand F, Mahmoodi M, Lotfi M, Zamiri N, Heydar ST, et al. non- alcoholic fatty liver disease in southern iran: a population based study: p0451. Journal of Gastroenterology and Hepatology. 2013;28:197. 194. Lankarani KB, Eshraghian K, Malek-Hosseini SA, Janghorban P, Geramizadeh B, Eshraghian A. Outcomes of liver transplantation for patients with acute liver failure. Archives of Iranian medicine. 2013;16(2):64. 195. Lankarani KB, Alavian SM, Peymani P. Health in the Islamic Republic of Iran, challenges and progresses. Medical journal of the Islamic Republic of Iran. 2013;27(1):42. 196. Lankarani KB, Alavian SM. Lessons learned from past cholera epidemics, interventions which are needed today. Journal of research in medical sciences: the official journal of Isfahan University of Medical Sciences. 2013;18(8):630. 197. Lankarani KB. Aspirin for the Primary Prophylaxis of Colorectal Cancer. Annals of Colorectal Research. 2013;1(3):77-80. 198. Lankarani KB. Mesenteric Vein Thrombosis Complicating Pneumatosis Intestinalis, a Case Report. Annals of Colorectal Research. 2013;1(2):71-2. 199. Lankarani KB. Why colorectal diseases are important. Ann Colorectal Res. 2013;1(1):1-2. 200. Lankarani KB. Liver Transplantation for Quality as well as Quantity of Life. Hepatitis monthly. 2013;13(10). 201. Lankarani K. Bisphosphonates and colon cancer. Osteoporosis International. 2013:1-2. 202. Lankarani K. rapid infliximab infusion is not always safe. Alimentary pharmacology & therapeutics. 2013;38(7):844-. 203. Honarvar B, Odoomi N, Moghadami M, Kazerooni PA, Hassanabadi A, Dolatabadi PZ, et al. Blood-borne hepatitis in opiate users in iran: a poor outlook and urgent need to change nationwide screening policy. PLoS One. 2013;8(12):e82230. 204. Honarvar B, Moghadami M, Moattari A, Emami A, Odoomi N, Lankarani KB. Seroprevalence of anti-rubella and anti-measles IgG antibodies in pregnant women in Shiraz, Southern Iran: outcomes of a nationwide measles-rubella mass vaccination campaign. PLoS One. 2013;8(1):e55043. 205. Honarvar B, Lankarani KB, Odoomi N, Roudgari A, Moghadami M, Kazerooni PA, et al. Pulmonary and latent tuberculosis screening in opiate drug users: an essential and neglected approach for harm-reduction facilities. Journal of addiction medicine. 2013;7(4):230-5. 206. Heydari ST, Sarikhani Y, Moafian G, Aghabeigi MR, Mahmoodi M, Ghaffarpasand F, et al. Time analysis of fatal traffic accidents in Fars Province of Iran. Chinese journal of traumatology. 2013;16(2):84-8. 207. Heydari ST, Ahmadi SM, Lankarani KB, Joulaei H, Hoseinzadeh A. Relationship between energy, macronutrient and micronutrient consumption with obesity among school aged students in Shiraz, Fars. Shiraz E-Medical Journal. 2013;14(3):202-10. 208. Erjaee G, Ostadzad M, Amanpour S, Lankarani K. Dynamical analysis of the interaction between effector immune and cancer cells and optimal control of chemotherapy. Nonlinear Dyn Psychol Life Sci. 2013;17(4):449-63. 209. Asgari S, Moslem M, Bagheri-Lankarani K, Pournasr B, Miryounesi M, Baharvand H. Differentiation and transplantation of human induced pluripotent stem cell-derived hepatocyte-like cells. Stem Cell Reviews and Reports. 2013;9(4):493-504. 210. Akbarzadeh Baghban A, Pourhoseingholi A, Zayeri F, Jafari AA, Alavian SM. Application of zero-inflated Poisson mixed models in prognostic factors of hepatitis C. BioMed research international. 2013;2013. 211. Ahmadi SM, Mohammadi MR, Mostafavi S-A, Keshavarzi S, Kooshesh S-M-A, Joulaei H, et al. Dependence of the geriatric depression on nutritional status and anthropometric indices in elderly population. Iranian journal of psychiatry. 2013;8(2):92. 212. Taghavi SA, Lankarani KB, Moini M, Hamidpour L, Ardebili M, Mansoorabadi Z. Establishment of a population–based registry of inflammatory bowel diseases in Fars province, Iran. Middle East journal of digestive diseases. 2012;4(2):97. 213. Peymani P, Maharlouei N, Joulaie H, Sadeghi E, Jahani P, Ahmadi SM, et al. Consumption’s Pattern and Knowledge of Athletes about Energy Drink in South of Iran (Shiraz). Pakistan Journal of Nutrition. 2012;11(8):670-5. 214. Maharlouei N, Zakeri Z, Mazloomi E, Lankarani KB. Maternal mortality rate in Fars Province: trends and associated factors in a community-based survey. Archives of Iranian medicine. 2012;15(1):14. 215. Maharlouei N, Lankarani K. 1359 Neonatal Mortality and Morbidity in Different Socioeconomic Classes in Southwest of Iran. Archives of Disease in Childhood. 2012;97(Suppl 2):A387-A. 216. Lankarani KB, Mahmoodi M, Gholami S, Mehravar S, Malekhosseini SA, Heydari ST, et al. Reducing social disparity in liver transplantation utilization through governmental financial support. Hepatitis monthly. 2012;12(11). 217. Lankarani KB, Haghdoost A, Smith P. Embargo on publication of scientific papers by Iranian authors. The Lancet. 2012;380(9842):648-9. 218. Lankarani KB. Iranian and American Health Professionals working together to Address Health Disparities in Mississippi Delta based on Iran's Health House Model. Archives of Iranian Medicine. 2012;15(6):378. 219. Joulaei H, Lankarani KB, Shahbazi M. Iranian and American health professionals working together to address health disparities in Mississippi Delta based on Iran's Health House model. Archives of Iranian medicine. 2012;15(6):378-80. 220. Honarvar B, Moghadami M, Moattari A, Emami A, Tabatabaee HR, Jahromi BN, et al. Titering of 2009 pandemic H1N1 influenza virus hemagglutinin inhibition antibody in nonvaccinated pregnant women in Shiraz, Southern Iran. Human vaccines & immunotherapeutics. 2012;8(5):604-11. 221. Haghighi AB, Banihashemi MA, Zamiri N, Sabayan B, Heydari ST, Safari A, et al. Seasonal variation of Guillain-Barre syndrome admission in a large tertiary referral center in southern Iran: a 10 year analysis. Acta Neurologica Taiwanica. 2012;21(2):60-6321. 222. Geramizadeh B, Fattahi MR, Lankarani KB. Castleman’s disease of the porta hepatis. Middle East journal of digestive diseases. 2012;4(3):180. 223. Fallahzadeh MK, Dormanesh B, Sagheb MM, Roozbeh J, Vessal G, Pakfetrat M, et al. Effect of addition of silymarin to renin-angiotensin system inhibitors on proteinuria in type 2 diabetic patients with overt nephropathy: a randomized, double-blind, placebo-controlled trial. American Journal of Kidney Diseases. 2012;60(6):896-903. 224. Boostani R, Rismanchi M, Khosravani A, Rashidi L, Kouchaki S, Peymani P, et al. Presenting a hybrid method in order to predict the2009 pandemic influenza A (H1N1). Advanced Computing. 2012;3(1):31. 225. Alavian SM, Lankarani KB, Sharara AI. Treatment of chronic HCV in special populations: Thalassemia, hemophilia, and hemodialysis patients. Current Hepatitis Reports. 2012;11(4):256-62. 226. Alavian SM, Lankarani KB, Rizzetto M, Marzano A, Moghadami M, Nik-Eghbolian S, et al. Management of Hepatitis B Virus Infection in Liver Transplantation Setting; The Rising Concerns and Growing Hopes, Report From 10th Congress of the Iranian Society for Organ Transplantation, 2011, Shiraz, Iran. Hepatitis monthly. 2012;12(12). 227. Alavian SM, Lankarani KB. Hepatitis B virus infection; a vanishing disease in Iranian children. J Compr Ped. 2012;3(1):1-2. 228. Zolghadr Asli A, Moghadami M, Zamiri N, Heidari S, Tolide-ei H, Lankarani K. Immunization against viral hepatitis B among prisoners in Iran: a comparison between accelerated vs. classic vaccination protocols. Hepatol Int. 2011;5(1):503-4. 229. Shayesteh AA, Zamiri N, Peymani P, Zargani FJ, Lankarani KB. A novel management method for disseminated intravascular coagulation like syndrome after a sting of Hemiscorpius lepturus: a case series. Trop Biomed. 2011;28(3):518-23. 230. Rezaianzadeh A, Heydari S, Hosseini H, Haghdoost A, Barooti E, Lankarani K. Prevalence of breast cancer in a defined population of iran. Iranian Red Crescent Medical Journal. 2011;13(9):647. 231. Masoompour SM, Yarmohammadi H, Rezaianzadeh A, Lankarani KB. Cancer incidence in southern Iran, 1998–2002: Results of population-based cancer registry. Cancer epidemiology. 2011;35(5):e42-e7. 232. Maharlouei N, Maani L, Lankarani K. Neonatal Mortality in South-West of Iran: Rates and Associated Factors. Pediatric Research. 2011;70(S5):671. 233. Lankarani KB, Zamiri N, Kabir A. Commentary on: Knowledge, attitude and practice of Iranian medical specialists regarding hepatitis B and C virus infection/Author's reply: Knowledge, attitudes, and practices of Iranian medical specialists. Hepatitis Monthly. 2011;11(1):41. 234. Lankarani KB, Alavian SM, Haghdoost AA. Disclosure of conflict of interest should not be a decorative statement–Authors' reply. The Lancet. 2011;377(9773):1239-40. 235. Lankarani KB. Somalia Famine, another Predictable Disaster in the New Millennium. Iranian Red Crescent Medical Journal. 2011;13(9):608. 236. Lankarani KB. The necessity of booster vaccination after neonatal hepatitis B vaccination. Hepatitis monthly. 2011;11(6):419. 237. Lankarani K. From Hiroshima to Fukushima. Iranian Red Crescent Medical Journal. 2011;13(8):528-9. 238. Lankarani K. Germany outbreak of Escherichia Coli, Lessons to be learned. Iranian Red Crescent Medical Journal. 2011;13(6):372. 239. Kabir A, Alavian S, Tabatabaei S, Lankarani K. Epidemiology of HCV Infection among Thalassemia Patients in Eastern Mediterranean Countries: Some Comments/Reply to Dr Kabir comments. Iranian Red Crescent Medical Journal. 2011;13(2):144. 240. Gouya M, Nabavi M, Soroush M, Haghdoust A, Ghalehee S, Hemmati P, et al. Mortality from pandemic influenza A (H1N1) in Iran. Iranian Red Crescent Medical Journal. 2011;13(10):698. 241. Borhani-Haghighi A, Lankarani KB. Swine flu (H1N1) infection among patients with neurologic disorders. A review of published evidence Neurosciences (Riyadh). 2011;16:213-6. 242. Asli AAZ, Moghadami M, Zamiri N, Tolide-ei HR, Heydari ST, Alavian SM, et al. Vaccination against hepatitis B among prisoners in Iran: accelerated vs. classic vaccination. Health policy. 2011;100(2-3):297-304. 243. Alavian S-M, Miri SM, Tabatabaei S-V, Keshvari M, Behnava B, Elizee PK, et al. Lipid profiles and hepatitis C viral markers in HCV-infected thalassemic patients. Gut and liver. 2011;5(3):348. 244. Alavian S, Lankarani K, Aalaei-Andabili S, editors. pouryasin A, Ebrahimi-Daryani N, Nassri- Toosi M, et al. Treatment of chronic hepatitis C infection: Update of the recommendation from scientific Lader's Meeting 28th July; 2011. 245. Ahmadi L, Kamkari S, Mokarram P, Lankarani KB, Tabibi N, Ashktorab H, et al. HER-2/neu and E-cadherin Expression and Microsatellite Instability in Gastric Dysplasia. Middle East journal of digestive diseases. 2011;3(1):20. 246. Sabayan B, Lankarani KB, Vaghefikia A. Are Patients with Malignancy More Prone to Swine Flu Complications? Current Status and Future Strategic Plans. Middle East Journal of Cancer. 2010;1(1):37- 9. 247. Moghadami M, Kazeroni PA, Honarvar B, Ebrahimi M, Bakhtiari H, Akbarpour M, et al. Influenza A (H1N1) virus pandemic in Fars province: a report from southern Iran, July-December 2009. Iranian Red Crescent Medical Journal. 2010;12(3):231. 248. Lankarani KB, Alavian SM, Haghdoost AA. Family physicians in Iran: success despite challenges. The Lancet. 2010;376(9752):1540-1. 249. Lankarani KB. Hajj and Swine Flu Pandemic (H1N1, 2009): What Is Expected and What Should Be Done? Iranian Red Crescent Medical Journal. 2010;12(1):4. 250. Lankarani K, Sabayan B. H1N1 influenza pandemics 2009: from myths to facts. Iranian Red Crescent Medical Journal. 2010;12(4):354. 251. Lankarani K. Pakistan Floods. Iranian Red Crescent Medical Journal. 2010;12(6):606. 252. Keshvari M, Alavian S, Behnava B, Miri S, Elizee PK, Tabatabaei S, et al. Distribution of hepatitis C virus genotypes in iranian patients with congenital bleeding disorders. Iranian Red Crescent Medical Journal. 2010;12(6):608. 253. Joulaei H, Honarvar B, Zamiri N, Moghadami M, Lankarani K. Introduction of a pyramidal model based on primary health care: A paradigm for management of 2009 H1N1 flu pandemic. Iranian Red Crescent Medical Journal. 2010;12(3):224. 254. Iravani S, Sabayan B, Sedaghat S, Heydari S, Javad P, Lankarani K, et al. The association of elevated serum alanine aminotransferase with metabolic syndrome in a military population in southern iran. Age (Years). 2010;30(108):29.6. 255. Hashemi S, Moghadami M, Lankarani K, Alborzi A, Mahbudi A. The efficacy of hepatitis B vaccination among school age children in Southern Iran. Iranian Red Crescent Medical Journal. 2010;12(1):45. 256. Gooya MM, Soroush M, Mokhtari-Azad T, Haghdoost AA, Hemati P, Moghadami M, et al. Influenza A (H1N1) pandemic in Iran: report of first confirmed cases from June to November 2009. Archives of Iranian Medicine (AIM). 2010;13(2). 257. Ghayumi SMA, Mehrabi S, Zamirian M, Haseli J, Lankarani KB. Pulmonary complications in cirrhotic candidates for liver transplantation. Hepatitis monthly. 2010;10(2):105. 258. Geramizadeh B, Malek-Hosseini S-A, Bahador A, Salahi H, Nikeghbalian S, Sharifian M, et al. Post-transplantation lymphoproliferative disorder after liver transplantation: report of 5 cases among more than 550 liver transplants in Iran. Archives of Iranian medicine. 2010;13(5):417. 259. Barooti E, Haghdoost A, Hosseini H, Tabibzadeh Z, Bahmani S, Tayeri S, et al. Vulnerable household women’s health assessment (VH-WHAT): protocol design and implementation. Iran Red Crecsent Med J. 2010;12(4):358-64. 260. Alavian SM, Zamiri N, Gooya MM, Tehrani A, Heydari ST, Lankarani KB. Hepatitis B vaccination of adolescents: a report on the national program in Iran. Journal of public health policy. 2010;31(4):478-93. 261. Alavian SM, Tabatabaei SV, Keshvari M, Behnava B, Miri SM, Elizee PK, et al. Peginterferon α‐2a and ribavirin treatment of patients with haemophilia and hepatitis C virus infection: a single‐centre study of 367 cases. Liver International. 2010;30(8):1173-80. 262. ALAVIAN SM, Kabir A, Ahmadi AB, Lankarani KB, Shahbabaie MA, AHMADZAD‐ASL M. Hepatitis C infection in hemodialysis patients in Iran: a systematic review. Hemodialysis International. 2010;14(3):253-62. 263. Alavian SM, Fallahian F, Lankarani KB. Implementing strategies for hepatitis B vaccination. Saudi Journal of Kidney Diseases and Transplantation. 2010;21(1):10. 264. Alavian S, Tabatabaei S, Lankarani K. Epidemiology of HCV infection among thalassemia patients in eastern Mediterranean countries: a quantitative review of literature. Iranian Red Crescent Medical Journal. 2010;12(4):365. 265. Majdzadeh R, Nedjat S, Keshavarz H, Rashidian A, Eynollahi B, Larijani B, et al. A new experience in medical student admission in Iran. Iran J Public Health. 2009;38(Suppl 1):36-9. 266. Larijani B, Majdzadeh R, Delavari A, Rajabi F, Khatibzadeh S, Esmailzadeh H, et al. Iran’s health innovation and science development plan by 2025. Iranian J Publ Health. 2009;38(1):13-6. 267. Lankarani K, editor Extrahepatic manifestations of chronic hepatitis C. 2nd Tehran Hepatitis Congress, Tehran, Iran, 7-9 October 2009; 2009: Baqiyatallah Research Center for Gastroenterology and Liver Diseases. 268. Khademolhosseini F, Malekhosseini S, Salahi H, Nikeghbalian S, Bahador A, Lankarani KB, et al. Outcome and characteristics of patients on the liver transplant waiting list: Shiraz experience. Middle East Journal of Digestive Diseases (MEJDD). 2009;1(2):63-7. 269. Haghighi PH, Lankarani KB, Taghavi SAR, Marvasti VE. Acute Mesenteric Ischemia: Causes and Mortality. Middle East Journal of Digestive Diseases (MEJDD). 2009;1(1):23-9. 270. Farshad S, Japoni A, Alborzi A, Lankarani KB, Taghavi S, Hosseini M. Immunodominant Antigens of Helicobacter pylori Strains Isolated from Patients with Different Gastroduodenal Diseases. Scientific Journal of Hamadan University of Medical Sciences. 2009;16(1):16-22. 271. Alavian SM, Miri SM, Keshvari M, Elizee PK, Behnava B, Tabatabaei SV, et al. Distribution of hepatitis C virus genotype in Iranian multiply transfused patients with thalassemia. Transfusion. 2009;49(10):2195-9. 272. Alavian SM, Ahmadzad-Asl M, Lankarani KB, Shahbabaie MA, Ahmadi AB, Kabir A. Hepatitis C infection in the general population of Iran: a systematic review. Hepatitis Monthly. 2009;9(3). 273. Vasei M, Monabbati A, Alizadeh-Naeeni M, Houshmand S, Azarpira N, Lankarani KB, et al. Immunoglobulin and complement depositions in the liver of chronic hepatitis patients. Hepato- gastroenterology. 2008;55(84):1066-70. 274. Tamizifar B, Lankarani K, Naeimi S, Zadeh MR, Taghavi A, Ghaderi A. Promoter polymorphism of transforming growth factor-β1 gene and ulcerative colitis. World Journal of Gastroenterology: WJG. 2008;14(2):243. 275. Marzban S, Geramizadeh B, Malek-Hosseini S-A, Bahador A, Salahi H, Bagheri-Lankarani K, et al. Post Transplantation Lymphoproliferative Disorder After Liver Transplantation: A Single Center Experience Among 400 Patient Series: 2323. Transplantation. 2008;86(2S):759. 276. Hasanpour P, Lankarani KB. Acute mesenteric ischemia: a comparative study of causes and mortality rates in Shiraz, Southern Iran. Critical Care. 2008;12(2):P257. 277. Haghighi PH, Lankarani KB, Taghavi SA, Marvasti VE. Acute mesenteric ischemia: causes and mortality rates over sixteen years in southern Iran. Indian J Gastroenterol. 2008;27(6):236-8. 278. Banani SJ, Lankarani KB, Taghavi A, Bagheri MH, Sefidbakht S, Geramizadeh B. Comparison of metoclopramide oral tablets and solution in treatment of dysmotility-like dyspepsia. American Journal of Health-System Pharmacy. 2008;65(11):1057-61. 279. Alavian SM, Hajarizadeh B, Ahmadzad-Asl M, Kabir A, Bagheri-Lankarani K. Hepatitis B Virus infection in Iran: A systematic review. Hepatitis monthly. 2008;8(4). 280. Haghighi AB, Ansari N, Mokhtari M, Geramizadeh B, Lankarani KB. Multiple sclerosis and gluten sensitivity. Clinical neurology and neurosurgery. 2007;109(8):651-3. 281. Bafandeh Y, Saberi Firoozi M, Bagheri Lankarani K. Evaluation of combination therapy with interferon and ribavirin in patients with chronic hepatitis C: A genotype based study. Journal of Mazandaran University of Medical Sciences. 2007;17(57):9-16. 282. Alavian SM, Fallahian F, Lankarani KB. The changing epidemiology of viral hepatitis B in Iran. Journal of Gastrointestinal and Liver Diseases. 2007;16(4):403. 283. Saberifiroozi M, Serati AR, Malekhosseini SA, Salahi H, Bahador A, Lankarani KB, et al. Analysis of patients listed for liver transplantation in Shiraz, Iran. Indian Journal of Gastroenterology. 2006;25(1):11. 284. Lankarani KB, Karbasi A, Kalantari T, Yarmohammadi H, SABERI‐FIROOZI M, ALIZADEH‐NAEENI M, et al. Analysis of cytotoxic T lymphocyte associated antigen 4 gene polymorphisms in patients with ulcerative colitis. Journal of gastroenterology and hepatology. 2006;21(2):449-53. 285. Lankarani KB. Iran seeks nuclear power to replace reliance on oil. Nature. 2006;443(7114):906. 286. Kumar PV, Monabati A, Naini MA, Lankarani KB, Fattahi MR, Asadilari M. Gastric Xanthoma. Acta cytologica. 2006;50(1):74-9. 287. Kazemi MS, Eshraghian K, Omrani G, Lankarani KB, Hosseini E. Homocysteine level and coronary artery disease. Angiology. 2006;57(1):9-14. 288. Kamali-Sarvestani E, Bazargani A, Masoudian M, Lankarani K, Taghavi A-R, Saberifiroozi M. Association of H pylori cagA and vacA genotypes and IL-8 gene polymorphisms with clinical outcome of infection in Iranian patients with gastrointestinal diseases. World journal of gastroenterology: WJG. 2006;12(32):5205. 289. Haghighi AB, Houlden H, Lankarani KB, Taghavi A, Masnadi K, Ashraf AR, et al. A novel DNA sequence variation in the first genetically confirmed Allgrove syndrome in Iran. Journal of clinical neuromuscular disease. 2006;7(3):123-7. 290. Behzad-Behbahani A, Mafi-Nejad A, Tabei S, Lankarani K. Anti-HBc & HBV-DNA detection in blood donors negative for hepatitis B virus surface antigen in reducing risk of transfusion associated HBV infection. Indian Journal of Medical Research. 2006;123(1):37. 291. Behbahani A, Nejad A, Tabei S, Lankarani K, Torab A. Moaddeb. Anti-HBc & HBV-DNA detection in blood donors negative for hepatitis B virus surface antigen in reducing risk of transfusion associated HBV infection. Indian J Med Res. 2006;123:37-42. 292. Shams M, Sharif-Kazemi M, Lankarani K, Sadegholvad A, Omrani G. Are Serum Thyrotropin level and Subclinical Hypothyroidism Predisposing Factors for Coronary Artery Disease? International Journal of Endocrinology and Metabolism. 2005;2005(2, Spring):67-73. 293. Roozbeh J, Moini M, Lankarani KB, Sagheb MM, Shahpoori S, Bastani B. Low dose intradermal versus high dose intramuscular hepatitis B vaccination in patients on chronic hemodialysis. ASAIO journal. 2005;51(3):242-5. 294. Lankarani K, Masoompour S, Masoompour M, Malekzadeh R, Tabei S, Haghshenas M. Changing epidemiology of IPSID in Southern Iran. Gut. 2005;54(2):311-2. 295. Lankarani K. Mycophenolate mofetil for the treatment of primary sclerosing cholangitis. Alimentary pharmacology & therapeutics. 2005;21(10):1279-80. 296. Hosseini SV, Haghbeen M, Yarmohammadi H, Lankarani KB, Kaviani MJ, Sharifzad HR. The therapeutic value of elective laparoscopic appendectomy in the management of chronic abdominal pain. Saudi medical journal. 2005;26(9):1482. 297. Haghighi AB, Malekhoseini S, Bahramali E, Firouzabadi N, Salahi H, Bahador A, et al., editors. Neurological complications of first 100 orthotopic liver transplantation patients in southern Iran. Transplantation proceedings; 2005: Elsevier. 298. Lankarani KB. Acute Hepatitis C Infection. Hepatitis Monthly. 2004;4(7):43-8. 299. Lankarani K, Moghadami M, Masoumpoor M, Geramizadeh B, Omrani G. Serum leptin level in patients with functional dyspepsia. Digestive and liver disease. 2004;36(11):717-21. 300. Alavian SM, Mirmomen S, Lankarani KB, Adibi P, Merat S. What is the optimal treatment? Hepatitis Monthly. 2004;4(4):5-6. 301. Alavian SM, Mirmomen S, Lankarani KB, Adibi P, Merat S. Management of hepatitis C infection (regional guideline). Hepatitis Monthly. 2004;4(4):1-10. 302. Zamani A, Omrani G, Lankarani K. Hyperhomocysteinaemia, hyperlipidaemia and risk of venous thromboembolism in Shiraz. East Mediterr Health J. 2003;9(5-6):935-43. 303. Lankarani KB. Use of mycophenolate mofetil in the treatment of primary sclerosing cholangitis. Journal of clinical gastroenterology. 2003;36(1):86. 304. Malek-Hosseini S-A, Salahi H, Lahsai M, Bahador A, Bagheri-Lankarani K, Fattahi M-R, et al. The first report of liver transplantation in Iran. Arch Iran Med. 2002;5:213-5. 305. Lankarani KB, Geramizadeh B, Salahi H. An unexpected cause of hemobilia. Journal of clinical gastroenterology. 2001;32(5):457. 306. Lankarani KB. Mortality associated with infliximab. Journal of clinical gastroenterology. 2001;33(3):255-6. 307. Lankarani K, Taghavi A, Agah S, Karimi A. Comparison of intradermal and intramuscular administration of hepatitis B vaccine in neonates. Indian journal of gastroenterology: official journal of the Indian Society of Gastroenterology. 2001;20(3):94-6. 308. Safari A, Lankarani KB. Mitochondrial Neurogastrointestinal Encephalomyopathy á. 309. Peymani P, Yeganeh B, Sabour S, Geramizadeh B, Fattahi MR, Keyvani H, et al. New use of an old drug: Chloroquine reduces viral and ALT levels in HCV non-responders (A randomized, triple-blind, placebo-controlled pilot trial-NCT02058173). 310. Mooghali A, Lankarani K. Abedi, h. Sarikhani, y.(2015): The Relationship between Job Characteristics and Work-Family Conflict among Married Women Employed In Clinical Wards of Shiraz University–Affiliated hospitals. Womens health Bulletin.2(1):1-6. 311. Mani A, Amini M, Sagheb MM, Kojuri J, Mirzajani H, Lankarani KB. Designing a psycho- educational cohort system in Shiraz Medical School. 312. Malek-Hosseini S-A, Heshmatollah Salahi M, Masoud Lahsai M, Ali Bahador M, Bagheri- Lankarani K, Mohammad-Reza Fattahi M, et al. Department of Organ Transplantation, Shiraz University of Medical Sciences, Shiraz, Iran. 313. Heydari ST, Sarikhani Y, Lankarani KB, Shirazi MK. Alternative formats. 314. Haghighi PH, Lankarani KB, Taghavi S, Emad V. Acute Mesenteric Ischemia: Causes and Mortality Rate in Shiraz, Southern Iran. 315. Ghorbani G, Mahboobi N, Lankarani K, Alavian S. Rescuers Be Immunized.

Presentations & Abstracts

1. Bagheri Lankarani K, Functional Gastrointestinal disorders in Medical students In Iran, Digestion 1998, 59(suppl 3). 678 2. Bagheri Lankarani K; Tavassoli A; Upper Gastrointestinal Bleeding in patients with chronic renal failure, Digestion 1998: 59(supple 3), 72. 3. Bagheri Lankarani K, Iliocolitis and Enterocutaneous fistulas in a patient with Behcet’s disease. Digestion 1998:59(suppl 3) 109. 4. Bagheri Lankarani K; Hosseini K; Ghahramani N; Raisjalali GA; Soveid M; Ramzi, M; Ghayyomi S.M; A preliminary Report on Internal evaluations in department of internal medicine, A report presented to ministry of Health and Medical Education Shiraz, Iran, 1999. 5. Ranjbar Omrani G.H; Bagheri Lankarani K, Kaviani M.J; Sharifkazemi M.B. Mucoromycosis in Fars, In: Proceedings of the 3rd Iranian Congress of Internists. Mashad, Iran 1992 6. Sadegholvaad AS, Kaviani, MJ; Bagheri lankarani K, Prevalence of endemic Goiter In students, Relation to hypothyroidism. In: Proceeding of the 3rd Iranian Congress of Internists, Mashad Iran, 1992. 7. Bagheri Lankarani K, Rajaii A, Samangoii S, Shorafa, A. Behcet’s disease in Fars, In: Proceedings of the 6th International congress of Geographic Medicine. Shiraz, Iran, 1993. 8. Saberifirozi M, Malekzadeh R, Bagheri Lankarani K. Antibodies to Hepatitis C virus In chronic liver disease in Iran: Its prevalence and clinical presentation. In: Proceedings of the 5th Iranian congress of Internists, Isfahan, Iran.1994 9. Saberifirouzi M, Alizadeh Naiinee M, Kheiri MA, Dehghani M; Dehbashi N; Bagheri Lankarani K; Fattahi MR; Eradication of H. Pylori in Non Ulcer Dyspepsia, In: Proceedings of the 5th Iranian Congress of Internists. Isfahan, Iran 1994 10. Baheri Lankarani K, Rozbeh J, Gastric lymphoma in Southern Iran, Review of 20 Years a clinicopathological report with Emphasis on the role of Helicobacter pylori. In: Proceedings of the 10th International congress of Geographic Medicine. Shiraz, Iran, 1997. 11. Bagheri Lankarani K; Karimi A; Agah S; Taghavi S.A.R; Hepatitis B vaccination Comparison of Intra muscular & Intra-dermal routes in neonates. In: Proceedings of the 11th International congress of Geographic Medicine, Shiraz, Iran, 1998. 12. Bagheri Lankarani K; Medical Research Dilemmas. In: Proceedings of the 11th International congress of Geographic medicine. Shiraz, Iran, 1998. 13. Lankarani K.B., Asadian F, Epidemiology of esophageal cancers in Fars province, Iran. Gut 2000, 47 (suppl 3): A71 14. Lankarani K.B., Tavakoli AR, Mowla A, Sagheb MM, Tabatabayii HR, Panjeshahin MR, Dyspepsia, GERD and headache are they related? Gut 2000; 47 (suppl 3): A88 15. Lankarani K.B., Merrikhi A, Sagheb MM, Tavakoli AR, Afarid M. The prevalence of dyspepsia and gastroesophageal reflux disease in a rural community in south of Iran. Gut 2001: 49 (suppl III): A-1831 16. Lankarani K.B., Afarid M., Tavakoli AR, Merrikhi A, Sagheb MM, Prevalence of irritable o\bowel syndrome in a rural community in south of Iran. Gut 2001: 49 (suppl III): A-1795 17. Lankarani K.B., Ghanbarian K, Acute mesenteric ischemia, experience from three centers in Shiraz, Iran. Gut 2001: 49 (suppl III): A-1185 18. Lankarani K.B., Asadi Poya K, Gastrointestinal disorders among male athletes, report from Iranian medical students Olympiad. Gut 2001: 49(suppl III): A-1220 19. Lankarani K.B., Tavakoli AR, Joghataii P, Khalilian R, Panjeshahin MR, Tabei SZ, Akbari Moghadam F, Epidemiology of colonic cancer in Fars province, Iran in past 22 years. Gut 2001: 49(suppl III): A-1599 20. Lankarani K.B., Nabavi SA, Tavakoli AR, Mowla A, Panjeshahin MR, Short term impacts of medical students’ research in gastroenterology. Gut 2001: 49(suppl III): A-1293 21. Lankarani K.B., Tavakoli AR, Afraid M., Sagheb MM, Merrikhi A., Geramizadeh B. Prevalence of helicobacter pylori and gastritis in a rural community in south of Iran. Gut 2001: 49(suppl III): A-1804 22. Lankarani K.B., Tavakoli AR, Akbari Moghadam F., Panjeshahin MR, Tabei SZ. Time trends in Epidemiology of liver cancers in Fars province, Iran in past 22 years. Gut 2001: 49(suppl III): A-1793 23. Lankarani K.B., Masompoor MB, Tabei SZ, Rayatpisheh S, Panjeshahin MR, Meshksari Z, Nabavizadeh SA, Akbari Moghadam F, Yadollahi M, Tavani R, Nadi M, Akbarzadeh A. Changes in Epidemiology of IPSID in Southern Iran. In the 12th world congress of Gastroenterology Bangkok, Thailand 2003